EUR 0.60 dividend per share, six shareholder representatives elected to the Supervisory Board, and resolutions, were all part of the recent Annual General Meeting of Gerresheimer AG.
EUR 0.60 dividend per share was approved at the Annual General Meeting of Gerresheimer AG, a leading partner to the pharma and healthcare industry, which was held at the end of April in Düsseldorf. A strong set of results was reported for the 2011 financial year at the AGM, where shareholders elected six shareholder representatives to the Supervisory Board, including new members Dr. Karin Dorrepaal and Dr. Peter Noé. At its meeting, the Supervisory Board re-elected Gerhard Schulze as its chairman.
“We achieved strong growth in revenues and profits in 2011. Our acquisition of the Brazilian market leader for pharmaceutical packaging made a positive contribution to this development. After getting off to a good start in the 2012 financial year, we made a further acquisition to improve our position in the emerging markets. Neutral Glass is our first production facility in the growth market of India. We intend to drive growth in the emerging markets over the next few years and consolidate our position in Europe and North America. This will be achieved by way of both organic growth and further acquisitions,“ summarized Uwe Röhrhoff, Chief Executive Officer of Gerresheimer AG, at the Annual General Meeting.
A dividend of EUR 0.60 per share was paid on 27 April 2012. Dividend income is tax-free for shareholders based in Germany. Last year the dividend was EUR 0.50 per share.
The following resolutions were passed at the Annual General Meeting with a share capital representation of 70.71%:
ITEM 2: Appropriation of net retained earnings for the financial year 2011: Votes in favour 99.99%
ITEM 3: Formal approval of the actions of the members of the Management Board in the financial year 2011: Votes in favour 99.95%
ITEM 4: Formal approval of the actions of the members of the Supervisory Board in the financial year 2011: Votes in favour 99.95%
ITEM 5: Election of the auditor for the financial year 2012: Votes in favour 99.90%
ITEM 6: New election of the Supervisory Board effective from April 26, 2012:
Dr. Karin Dorrepaal, votes in favour 97.69%
Dr. Peter Noé, votes in favour 97.69%
Mr. Hans Peter Peters, votes in favour 99.95%
Mr. Gerhard Schulze, votes in favour 98.68%
Mr. Theodor Stuth, votes in favour 97.68%
Mr. Udo J. Vetter, votes in favour 96.45%
ITEM 7: Authorization of the Management Board to increase the capital stock (authorized capital): Votes in favour 92.06%
ITEM 8: Authorization to issue convertible or warrant bonds: Votes in favour 92.28%.